Your browser doesn't support javascript.
loading
Epilepsy: expert opinion on emerging drugs in phase 2/3 clinical trials.
Pong, Amanda W; Ross, Jonathan; Tyrlikova, Ivana; Giermek, Alexander J; Kohli, Maya P; Khan, Yousef A; Salgado, Roger D; Klein, Pavel.
  • Pong AW; Mid-Atlantic Epilepsy and Sleep Center, Comprehensive Neurology Clinics of Bethesda, Bethesda, MD, USA.
  • Ross J; Mid-Atlantic Epilepsy and Sleep Center, Comprehensive Neurology Clinics of Bethesda, Bethesda, MD, USA.
  • Tyrlikova I; Mid-Atlantic Epilepsy and Sleep Center, Comprehensive Neurology Clinics of Bethesda, Bethesda, MD, USA.
  • Giermek AJ; Mid-Atlantic Epilepsy and Sleep Center, Comprehensive Neurology Clinics of Bethesda, Bethesda, MD, USA.
  • Kohli MP; Mid-Atlantic Epilepsy and Sleep Center, Comprehensive Neurology Clinics of Bethesda, Bethesda, MD, USA.
  • Khan YA; Mid-Atlantic Epilepsy and Sleep Center, Comprehensive Neurology Clinics of Bethesda, Bethesda, MD, USA.
  • Salgado RD; Mid-Atlantic Epilepsy and Sleep Center, Comprehensive Neurology Clinics of Bethesda, Bethesda, MD, USA.
  • Klein P; Mid-Atlantic Epilepsy and Sleep Center, Comprehensive Neurology Clinics of Bethesda, Bethesda, MD, USA.
Expert Opin Emerg Drugs ; 27(1): 75-90, 2022 03.
Article en En | MEDLINE | ID: mdl-35341431

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Epilepsia / Anticonvulsivantes Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Epilepsia / Anticonvulsivantes Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article